Compounds > troglitazone
Page last updated: 2024-11-05

troglitazone and Fractures, Bone

troglitazone has been researched along with Fractures, Bone in 1 studies

Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.

Fractures, Bone: Breaks in bones.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hampton, T1

Other Studies

1 other study available for troglitazone and Fractures, Bone

ArticleYear
Diabetes drugs tied to fractures in women.
    JAMA, 2007, Apr-18, Volume: 297, Issue:15

    Topics: Chromans; Female; Fractures, Bone; Humans; Hypoglycemic Agents; Pioglitazone; Rosiglitazone; Thiazol

2007